Patent · US Active

Production of thorium 228 starting from a natural thorium salt

US8221520B2 · kind B2 · utility

1Cited by
3References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 18, 2008
Grant dateJul 17, 2012
Priority date
Expiry dateMay 5, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC01P2006/88
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a process for producing 228Th from a natural thorium salt, which comprises in succession: a) the separation of the radium from the other radioelements present in this salt, by at least one coprecipitation of the radium by barium sulphate, this coprecipitation comprising: i) the addition of sulphuric acid and a barium salt to an aqueous solution of said natural thorium salt in order to form a barium-radium sulphate coprecipitate and ii) the separation of the coprecipitate from the medium in which it has formed; b) the extraction of the thorium 228 coming from the decay of radium 228 from the coprecipitate thus separated; and, optionally c) the purification and concentration of the 228Th thus extracted. Applications: manufacture of radiopharmaceutical products useful in nuclear medicine, in particular in radioimmunotherapy for the treatment of cancers and AIDS.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.